| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 31 | 2024 | 855 | 4.260 |
Why?
|
| Parkinson Disease | 21 | 2023 | 708 | 4.120 |
Why?
|
| tau Proteins | 15 | 2023 | 216 | 4.060 |
Why?
|
| Drosophila | 20 | 2023 | 839 | 2.160 |
Why?
|
| Drosophila Proteins | 14 | 2020 | 858 | 1.680 |
Why?
|
| alpha-Synuclein | 7 | 2023 | 118 | 1.630 |
Why?
|
| Genome-Wide Association Study | 26 | 2023 | 2265 | 1.600 |
Why?
|
| Drosophila melanogaster | 8 | 2019 | 829 | 1.420 |
Why?
|
| Parkinsonian Disorders | 10 | 2021 | 77 | 1.390 |
Why?
|
| Brain | 14 | 2023 | 4113 | 1.230 |
Why?
|
| Genetic Predisposition to Disease | 22 | 2023 | 5539 | 1.150 |
Why?
|
| Aging | 10 | 2023 | 1582 | 1.080 |
Why?
|
| Neurodegenerative Diseases | 4 | 2017 | 264 | 1.040 |
Why?
|
| Neurons | 13 | 2023 | 2287 | 1.010 |
Why?
|
| Tauopathies | 4 | 2021 | 63 | 1.000 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2023 | 4549 | 0.910 |
Why?
|
| Genetic Loci | 6 | 2019 | 481 | 0.890 |
Why?
|
| Wearable Electronic Devices | 2 | 2021 | 105 | 0.840 |
Why?
|
| Lysosomal Storage Diseases | 3 | 2019 | 35 | 0.830 |
Why?
|
| Lysosomes | 2 | 2023 | 347 | 0.800 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 11 | 0.790 |
Why?
|
| Lewy Bodies | 5 | 2021 | 10 | 0.780 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 58 | 0.760 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 443 | 0.730 |
Why?
|
| DNA Transposable Elements | 2 | 2018 | 222 | 0.720 |
Why?
|
| Tremor | 1 | 2021 | 128 | 0.710 |
Why?
|
| Endosomes | 1 | 2020 | 109 | 0.700 |
Why?
|
| Postural Balance | 1 | 2021 | 151 | 0.690 |
Why?
|
| Spliceosomes | 1 | 2019 | 75 | 0.690 |
Why?
|
| Cognition Disorders | 6 | 2021 | 786 | 0.680 |
Why?
|
| Proteostasis | 1 | 2019 | 52 | 0.670 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 135 | 0.670 |
Why?
|
| 14-3-3 Proteins | 1 | 2019 | 143 | 0.660 |
Why?
|
| Glucosylceramidase | 5 | 2023 | 22 | 0.660 |
Why?
|
| Multiple System Atrophy | 1 | 2018 | 19 | 0.660 |
Why?
|
| Nerve Degeneration | 1 | 2019 | 148 | 0.650 |
Why?
|
| Cytoskeletal Proteins | 2 | 2019 | 492 | 0.610 |
Why?
|
| RNA Splicing | 1 | 2019 | 370 | 0.610 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2017 | 110 | 0.600 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 487 | 0.560 |
Why?
|
| Animals, Genetically Modified | 7 | 2023 | 406 | 0.560 |
Why?
|
| Neurofibrillary Tangles | 2 | 2017 | 24 | 0.540 |
Why?
|
| Animals | 37 | 2023 | 59536 | 0.510 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 500 | 0.500 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2019 | 1439 | 0.500 |
Why?
|
| Cell Death | 1 | 2016 | 671 | 0.470 |
Why?
|
| Neurology | 1 | 2015 | 113 | 0.450 |
Why?
|
| DiGeorge Syndrome | 1 | 2013 | 77 | 0.450 |
Why?
|
| Amyloid beta-Peptides | 6 | 2024 | 246 | 0.450 |
Why?
|
| Apolipoprotein E4 | 2 | 2013 | 48 | 0.440 |
Why?
|
| Genetic Variation | 9 | 2019 | 2086 | 0.420 |
Why?
|
| Genome | 2 | 2018 | 672 | 0.420 |
Why?
|
| Receptors, Complement | 1 | 2012 | 48 | 0.420 |
Why?
|
| Humans | 77 | 2024 | 261506 | 0.410 |
Why?
|
| Phenotype | 10 | 2019 | 6295 | 0.390 |
Why?
|
| Genetic Association Studies | 7 | 2016 | 1084 | 0.370 |
Why?
|
| Databases, Genetic | 4 | 2019 | 745 | 0.340 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 7222 | 0.330 |
Why?
|
| Transcriptome | 4 | 2023 | 1859 | 0.330 |
Why?
|
| Genotype | 14 | 2020 | 4109 | 0.320 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 621 | 0.320 |
Why?
|
| Plaque, Amyloid | 4 | 2017 | 65 | 0.320 |
Why?
|
| Receptors, Complement 3b | 3 | 2012 | 20 | 0.300 |
Why?
|
| Genomics | 4 | 2023 | 2738 | 0.290 |
Why?
|
| Aged, 80 and over | 26 | 2021 | 29902 | 0.270 |
Why?
|
| Mutation | 10 | 2022 | 15179 | 0.260 |
Why?
|
| Longitudinal Studies | 8 | 2021 | 1945 | 0.260 |
Why?
|
| Female | 44 | 2021 | 141928 | 0.250 |
Why?
|
| Cognitive Dysfunction | 4 | 2024 | 333 | 0.250 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 651 | 0.250 |
Why?
|
| Cell Polarity | 3 | 2002 | 208 | 0.250 |
Why?
|
| Medicine in Literature | 1 | 2004 | 5 | 0.240 |
Why?
|
| Literature, Modern | 1 | 2004 | 8 | 0.240 |
Why?
|
| Drama | 1 | 2004 | 13 | 0.240 |
Why?
|
| Age of Onset | 4 | 2020 | 827 | 0.240 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2023 | 9 | 0.230 |
Why?
|
| RNA Interference | 3 | 2018 | 1408 | 0.230 |
Why?
|
| Male | 39 | 2021 | 123000 | 0.230 |
Why?
|
| Haplotypes | 3 | 2016 | 856 | 0.230 |
Why?
|
| Aged | 31 | 2021 | 70117 | 0.220 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2001 | 129 | 0.220 |
Why?
|
| Caenorhabditis elegans | 3 | 2017 | 268 | 0.210 |
Why?
|
| Motor Activity | 2 | 2019 | 693 | 0.210 |
Why?
|
| Protein Interaction Maps | 2 | 2021 | 149 | 0.210 |
Why?
|
| Cohort Studies | 12 | 2020 | 9244 | 0.210 |
Why?
|
| Apoptosis | 3 | 2012 | 7591 | 0.210 |
Why?
|
| Mitochondria | 2 | 2022 | 1282 | 0.200 |
Why?
|
| Neuroglia | 1 | 2023 | 223 | 0.200 |
Why?
|
| Patients | 1 | 2004 | 245 | 0.200 |
Why?
|
| Alleles | 7 | 2019 | 2437 | 0.200 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2019 | 49 | 0.200 |
Why?
|
| Insect Proteins | 2 | 2002 | 91 | 0.200 |
Why?
|
| Models, Biological | 3 | 2019 | 3254 | 0.200 |
Why?
|
| Apolipoproteins E | 7 | 2017 | 221 | 0.190 |
Why?
|
| Exome | 5 | 2017 | 1239 | 0.190 |
Why?
|
| Cytoskeleton | 2 | 2011 | 267 | 0.190 |
Why?
|
| Cathepsin B | 1 | 2020 | 32 | 0.180 |
Why?
|
| Surgical Procedures, Operative | 1 | 2004 | 383 | 0.180 |
Why?
|
| Lewy Body Disease | 1 | 2020 | 20 | 0.180 |
Why?
|
| Cell Physiological Phenomena | 1 | 1999 | 24 | 0.180 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2019 | 43 | 0.180 |
Why?
|
| Peptide Fragments | 3 | 2016 | 1271 | 0.180 |
Why?
|
| Cerebrospinal Fluid | 1 | 2020 | 120 | 0.180 |
Why?
|
| Helminth Proteins | 1 | 2000 | 107 | 0.180 |
Why?
|
| Penetrance | 1 | 2020 | 126 | 0.180 |
Why?
|
| Accelerometry | 1 | 2019 | 63 | 0.170 |
Why?
|
| Proteomics | 3 | 2021 | 1380 | 0.170 |
Why?
|
| Microglia | 1 | 2020 | 164 | 0.160 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 2 | 2019 | 21 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 2483 | 0.160 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 677 | 0.160 |
Why?
|
| Burnout, Professional | 1 | 2021 | 205 | 0.160 |
Why?
|
| Proteome | 2 | 2019 | 561 | 0.160 |
Why?
|
| Acid Ceramidase | 1 | 2017 | 5 | 0.160 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 2291 | 0.160 |
Why?
|
| Cathepsin D | 1 | 2017 | 32 | 0.160 |
Why?
|
| Organic Anion Transporters | 1 | 2017 | 21 | 0.160 |
Why?
|
| Risk Factors | 13 | 2021 | 17523 | 0.160 |
Why?
|
| Middle Aged | 21 | 2021 | 86204 | 0.160 |
Why?
|
| Substantia Nigra | 2 | 2021 | 41 | 0.150 |
Why?
|
| Case-Control Studies | 8 | 2020 | 6100 | 0.150 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2017 | 17 | 0.150 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 3 | 2012 | 5 | 0.150 |
Why?
|
| Symporters | 1 | 2017 | 98 | 0.150 |
Why?
|
| alpha Catenin | 1 | 2016 | 23 | 0.150 |
Why?
|
| Membrane Proteins | 4 | 2016 | 2819 | 0.150 |
Why?
|
| Tropomyosin | 1 | 2016 | 38 | 0.150 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 166 | 0.150 |
Why?
|
| Astrocytes | 1 | 2020 | 368 | 0.140 |
Why?
|
| Microelectrodes | 1 | 2016 | 52 | 0.140 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2016 | 73 | 0.140 |
Why?
|
| Prospective Studies | 7 | 2019 | 12873 | 0.140 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2016 | 14 | 0.140 |
Why?
|
| Polymorphism, Genetic | 2 | 2012 | 1450 | 0.140 |
Why?
|
| Electroretinography | 1 | 2016 | 116 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 252 | 0.140 |
Why?
|
| Tenascin | 1 | 2016 | 56 | 0.140 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 216 | 0.130 |
Why?
|
| Essential Tremor | 1 | 2016 | 85 | 0.130 |
Why?
|
| Vision, Ocular | 1 | 2016 | 157 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 3 | 2020 | 1491 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 264 | 0.130 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2016 | 196 | 0.130 |
Why?
|
| Membrane Potentials | 1 | 2016 | 424 | 0.130 |
Why?
|
| Atrophy | 2 | 2012 | 261 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 413 | 0.130 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 4320 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 1077 | 0.120 |
Why?
|
| Harm Reduction | 1 | 2014 | 16 | 0.120 |
Why?
|
| Proteins | 3 | 2016 | 1963 | 0.120 |
Why?
|
| Verbal Learning | 1 | 2014 | 84 | 0.120 |
Why?
|
| Age Factors | 5 | 2016 | 5377 | 0.120 |
Why?
|
| Arteriolosclerosis | 1 | 2013 | 2 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2020 | 992 | 0.120 |
Why?
|
| Executive Function | 1 | 2015 | 160 | 0.120 |
Why?
|
| Infarction | 1 | 2013 | 31 | 0.120 |
Why?
|
| Cognition | 4 | 2016 | 968 | 0.120 |
Why?
|
| CD11b Antigen | 1 | 2013 | 66 | 0.120 |
Why?
|
| Receptors, Notch | 1 | 2016 | 383 | 0.110 |
Why?
|
| Physicians | 1 | 2021 | 882 | 0.110 |
Why?
|
| Disease Progression | 4 | 2020 | 6682 | 0.110 |
Why?
|
| Time Perception | 1 | 2012 | 13 | 0.110 |
Why?
|
| Locus Coeruleus | 1 | 2012 | 33 | 0.110 |
Why?
|
| Period Circadian Proteins | 1 | 2012 | 52 | 0.110 |
Why?
|
| Retina | 1 | 2016 | 532 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 4053 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2016 | 1265 | 0.110 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2012 | 15 | 0.110 |
Why?
|
| Software | 1 | 2019 | 1321 | 0.110 |
Why?
|
| Memory, Episodic | 1 | 2012 | 32 | 0.100 |
Why?
|
| Microtubules | 3 | 2003 | 270 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 577 | 0.100 |
Why?
|
| Integrins | 1 | 2013 | 262 | 0.100 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2011 | 42 | 0.100 |
Why?
|
| Memory Disorders | 1 | 2014 | 295 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2012 | 1163 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 315 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2012 | 189 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2014 | 348 | 0.100 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 21 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2012 | 185 | 0.100 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2011 | 61 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2016 | 1152 | 0.100 |
Why?
|
| Neurofibrils | 1 | 2010 | 2 | 0.100 |
Why?
|
| Adult | 12 | 2019 | 77950 | 0.100 |
Why?
|
| Endocytosis | 1 | 2011 | 225 | 0.100 |
Why?
|
| Clusterin | 1 | 2010 | 28 | 0.090 |
Why?
|
| Hippocampus | 2 | 2017 | 915 | 0.090 |
Why?
|
| Neurites | 1 | 2010 | 63 | 0.090 |
Why?
|
| Base Sequence | 1 | 2017 | 4917 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 330 | 0.090 |
Why?
|
| Brain Mapping | 1 | 2013 | 644 | 0.090 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2016 | 137 | 0.090 |
Why?
|
| Odds Ratio | 2 | 2012 | 2316 | 0.090 |
Why?
|
| Quantitative Trait Loci | 1 | 2011 | 374 | 0.080 |
Why?
|
| Mice | 6 | 2020 | 34495 | 0.080 |
Why?
|
| Amyloid | 2 | 2024 | 97 | 0.080 |
Why?
|
| Species Specificity | 2 | 2020 | 777 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 1756 | 0.080 |
Why?
|
| Genetic Testing | 2 | 2013 | 1589 | 0.080 |
Why?
|
| Herpes Zoster Oticus | 1 | 2007 | 1 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 621 | 0.080 |
Why?
|
| Proline-Directed Protein Kinases | 1 | 2007 | 1 | 0.080 |
Why?
|
| Neurogenesis | 2 | 2020 | 238 | 0.080 |
Why?
|
| Peptides | 2 | 2003 | 1479 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2010 | 349 | 0.070 |
Why?
|
| Dementia | 1 | 2012 | 453 | 0.070 |
Why?
|
| Neuropathology | 2 | 2017 | 6 | 0.070 |
Why?
|
| Risk | 3 | 2017 | 1972 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 368 | 0.070 |
Why?
|
| Protein Kinases | 3 | 2007 | 874 | 0.070 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2007 | 113 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2013 | 908 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2021 | 1489 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2011 | 850 | 0.060 |
Why?
|
| Signal Transduction | 4 | 2011 | 11965 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2007 | 243 | 0.060 |
Why?
|
| Synucleins | 1 | 2003 | 13 | 0.060 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2003 | 29 | 0.060 |
Why?
|
| Ataxins | 1 | 2003 | 91 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 14889 | 0.060 |
Why?
|
| Ataxin-1 | 1 | 2003 | 148 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2003 | 161 | 0.050 |
Why?
|
| Depression | 1 | 2013 | 1715 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2017 | 5637 | 0.050 |
Why?
|
| Wings, Animal | 1 | 2002 | 62 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 311 | 0.050 |
Why?
|
| Chicago | 1 | 2021 | 40 | 0.050 |
Why?
|
| Feedback, Physiological | 1 | 2002 | 193 | 0.050 |
Why?
|
| Autopsy | 2 | 2012 | 173 | 0.050 |
Why?
|
| Transgenes | 1 | 2003 | 557 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 1697 | 0.050 |
Why?
|
| Epithelium | 1 | 2003 | 720 | 0.050 |
Why?
|
| Oocytes | 2 | 2001 | 414 | 0.050 |
Why?
|
| Oogenesis | 1 | 2001 | 71 | 0.050 |
Why?
|
| Independent Living | 1 | 2021 | 73 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2018 | 4821 | 0.050 |
Why?
|
| Interleukin-3 | 1 | 2000 | 96 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2006 | 2084 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 342 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2014 | 1546 | 0.040 |
Why?
|
| Emotions | 1 | 2024 | 562 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 1178 | 0.040 |
Why?
|
| Sample Size | 1 | 2020 | 202 | 0.040 |
Why?
|
| Niemann-Pick Diseases | 1 | 2019 | 4 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 22 | 0.040 |
Why?
|
| Galactosylceramidase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Sandhoff Disease | 1 | 2019 | 4 | 0.040 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2019 | 5 | 0.040 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2019 | 12 | 0.040 |
Why?
|
| Gaucher Disease | 1 | 2019 | 15 | 0.040 |
Why?
|
| Proton-Translocating ATPases | 1 | 2019 | 28 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 1678 | 0.040 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 17 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 901 | 0.040 |
Why?
|
| Mast Cells | 1 | 2000 | 223 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 336 | 0.040 |
Why?
|
| Argonaute Proteins | 1 | 2018 | 40 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 690 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 338 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 203 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 417 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 336 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 702 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 1 | 2018 | 117 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 3343 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2018 | 233 | 0.040 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2016 | 9 | 0.040 |
Why?
|
| K562 Cells | 1 | 2018 | 338 | 0.040 |
Why?
|
| Detergents | 1 | 2016 | 34 | 0.040 |
Why?
|
| Iceland | 1 | 2016 | 12 | 0.040 |
Why?
|
| Gene Library | 1 | 2018 | 294 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2016 | 73 | 0.040 |
Why?
|
| Phosphoproteins | 2 | 2002 | 1152 | 0.040 |
Why?
|
| Actins | 1 | 1999 | 608 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 1021 | 0.040 |
Why?
|
| Diagnosis | 1 | 2016 | 34 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 156 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 4988 | 0.030 |
Why?
|
| COS Cells | 1 | 2016 | 377 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2016 | 3536 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2016 | 331 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 6089 | 0.030 |
Why?
|
| Claudin-5 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 370 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 281 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2014 | 36 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 2173 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1338 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 275 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 259 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 842 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 432 | 0.030 |
Why?
|
| Young Adult | 3 | 2019 | 21445 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 769 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 269 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 1020 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 584 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2012 | 14 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 7702 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2007 | 1764 | 0.030 |
Why?
|
| Receptor, EphA1 | 1 | 2012 | 4 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2012 | 86 | 0.030 |
Why?
|
| Actigraphy | 1 | 2012 | 54 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6207 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 3 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2012 | 102 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2013 | 4804 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2013 | 179 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 3154 | 0.030 |
Why?
|
| Clathrin | 1 | 2011 | 34 | 0.030 |
Why?
|
| Secretory Pathway | 1 | 2011 | 16 | 0.030 |
Why?
|
| Biomarkers | 2 | 2020 | 5047 | 0.030 |
Why?
|
| Cell Count | 1 | 2012 | 508 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2018 | 1171 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 259 | 0.030 |
Why?
|
| Serine | 1 | 2013 | 388 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2013 | 311 | 0.030 |
Why?
|
| Glutamates | 1 | 2011 | 130 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 309 | 0.020 |
Why?
|
| HLA-B44 Antigen | 1 | 2010 | 2 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 1271 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 276 | 0.020 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 57 | 0.020 |
Why?
|
| Frizzled Receptors | 2 | 2002 | 25 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2011 | 240 | 0.020 |
Why?
|
| Dishevelled Proteins | 2 | 2002 | 59 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 756 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 4849 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2002 | 4233 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 5319 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 3639 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2020 | 6150 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 37905 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2010 | 225 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 482 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 3438 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 734 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 369 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 974 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1998 | 2488 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2013 | 549 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 538 | 0.020 |
Why?
|
| Monocytes | 1 | 2012 | 788 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 4143 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 445 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 6009 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 1213 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2002 | 652 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 1073 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 5159 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 3570 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 220 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2002 | 488 | 0.020 |
Why?
|
| Child | 2 | 2019 | 29154 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 2307 | 0.020 |
Why?
|
| Alanine | 1 | 2007 | 240 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2013 | 1555 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 3890 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 2139 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 1113 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 5673 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 12926 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 448 | 0.020 |
Why?
|
| Eye | 1 | 2007 | 301 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2013 | 1664 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 1144 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 11538 | 0.020 |
Why?
|
| Adolescent | 2 | 2017 | 31252 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 1823 | 0.010 |
Why?
|
| Body Patterning | 1 | 2003 | 212 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2003 | 161 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 6086 | 0.010 |
Why?
|
| Pupa | 1 | 2002 | 22 | 0.010 |
Why?
|
| LIM Domain Proteins | 1 | 2002 | 104 | 0.010 |
Why?
|
| Epistasis, Genetic | 1 | 2002 | 119 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 21713 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2001 | 80 | 0.010 |
Why?
|
| Microtubule Proteins | 1 | 2001 | 41 | 0.010 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2000 | 13 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2000 | 111 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2000 | 52 | 0.010 |
Why?
|
| Phosphopeptides | 1 | 2000 | 65 | 0.010 |
Why?
|
| Meiosis | 1 | 2001 | 166 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2000 | 124 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12221 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 483 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 611 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2006 | 1546 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 5270 | 0.010 |
Why?
|
| Wnt1 Protein | 1 | 1998 | 103 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 862 | 0.010 |
Why?
|
| Xenopus | 1 | 1998 | 219 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 1998 | 185 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 2049 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 597 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 1555 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 2944 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2002 | 929 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 7548 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 5395 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 2927 | 0.010 |
Why?
|
| Cell Line | 1 | 2000 | 5114 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 32848 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2001 | 4078 | 0.010 |
Why?
|